Zeneca/ Astra
Thursday, 1 April 1999
Featured In: April / May 1999 (Vol. 2 Iss. 2)
The European Commission has conditionally cleared the US$35 billion merger of pharmaceuticals companies Zeneca Group plc of the UK and Astra AB of Sweden, which will create the third-largest such company in the world.
PREMIUM Subscription required to view this article
This content can only be accessed by PREMIUM GCR subscribers.
A premium subscription includes 10 issues of the journal, 2 signature surveys - The GCR100 and Rating Enforcement, 10 GCR special reports and full access to current and archived print & online content.
If you are a GCR subscriber, please login to access this content:
Comments
You must Subscribe or Log In to make comments.
Comment Terms & Conditions
Back to April / May 1999 (Vol. 2 Iss. 2)
Back to top